These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

73 related articles for article (PubMed ID: 10452316)

  • 21. Follow-up of differentiated thyroid cancer: what is the value of FDG and sestamibi in the diagnostic algorithm?
    Dietlein M; Scheidhauer K; Voth E; Theissen P; Schicha H
    Nuklearmedizin; 1998 Jan; 37(1):12-7. PubMed ID: 9467164
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Overview of the current status of PET in breast cancer imaging.
    Wahl RL
    Q J Nucl Med; 1998 Mar; 42(1):1-7. PubMed ID: 9646639
    [TBL] [Abstract][Full Text] [Related]  

  • 23. 18-FDG imaging in breast cancer.
    Hoh CK; Schiepers C
    Semin Nucl Med; 1999 Jan; 29(1):49-56. PubMed ID: 9990683
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Positron emission tomography in thyroid cancer management.
    Larson SM; Robbins R
    Semin Roentgenol; 2002 Apr; 37(2):169-74. PubMed ID: 12134369
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Treating high thyroglobulin with radioiodine: a magic bullet or a shot in the dark?
    Mazzaferri EL
    J Clin Endocrinol Metab; 1995 May; 80(5):1485-7. PubMed ID: 7744990
    [No Abstract]   [Full Text] [Related]  

  • 26. [Diagnosis of colorectal cancer with FDG-PET].
    Uno K
    Nihon Rinsho; 2003 Sep; 61 Suppl 7():168-72. PubMed ID: 14574875
    [No Abstract]   [Full Text] [Related]  

  • 27. FDG PET in thyroid cancer: thyroxine or not?
    Grünwald F; Biersack HJ
    J Nucl Med; 2000 Dec; 41(12):1996-8. PubMed ID: 11138684
    [No Abstract]   [Full Text] [Related]  

  • 28. Clinical usefulness of FDG PET in differentiated thyroid cancer.
    Macapinlac HA
    J Nucl Med; 2001 Jan; 42(1):77-8. PubMed ID: 11197984
    [No Abstract]   [Full Text] [Related]  

  • 29. [Positron emission tomography (PET) in clinical oncology [Part III]].
    Cabrera Villegas A; García Velloso MJ; Gámez Cenzano C
    Rev Esp Med Nucl; 2002 Jul; 21(4):304-20; quiz 321-3. PubMed ID: 12206748
    [No Abstract]   [Full Text] [Related]  

  • 30. Use of FDG-PET in testicular tumours.
    Huddart RA
    Clin Oncol (R Coll Radiol); 2003 May; 15(3):123-7. PubMed ID: 12801049
    [No Abstract]   [Full Text] [Related]  

  • 31. Clinical PET in oncology.
    Biersack HJ; Bender H; Ruhlmann J; Oehr P; Guhlke S; Grünwald F
    Rev Esp Med Nucl; 2000 Jun; 19(3):219-24. PubMed ID: 11062087
    [No Abstract]   [Full Text] [Related]  

  • 32. [Nuclear medicine in oncology: new diagnostic and therapeutic methods].
    Maublant J; Lumbroso J; Cachin F; Raoul JL; Syrota A; Vuillez JP
    Bull Cancer; 2001 Jan; 88(1):35-44. PubMed ID: 11182651
    [No Abstract]   [Full Text] [Related]  

  • 33. [Metabolic imaging of a malignant myxofibrosarcoma with F-18-FDG and C-11-methionine positron emission tomography].
    Weckesser E; Redeker J; Kühnel G; Börner AR; Flügel M; Knapp WH
    Nuklearmedizin; 2000; 39(3):N38-9. PubMed ID: 10834199
    [No Abstract]   [Full Text] [Related]  

  • 34. FDG-PET in clinical oncology: review of the literature and report of one institution's experience.
    Oehr P; Ruhlmann J; Biersack HJ
    J Investig Med; 1999 Nov; 47(9):452-61. PubMed ID: 10572375
    [No Abstract]   [Full Text] [Related]  

  • 35. False-negative thyroglobulin measurement in recurrent/metastatic thyroid carcinomas.
    Giovanella L
    Eur J Nucl Med Mol Imaging; 2009 Feb; 36(2):326-7; author reply 328. PubMed ID: 19089422
    [No Abstract]   [Full Text] [Related]  

  • 36. Detection of gall bladder cancer metastases in rare sites by PET scan.
    Shukla PJ; Barreto SG; Shrikhande SV; Mohandas KM; Purandare N; Rangarajan V
    Indian J Gastroenterol; 2007; 26(6):303-4. PubMed ID: 18431025
    [No Abstract]   [Full Text] [Related]  

  • 37. Small cell carcinoma of the parotid gland: evaluation with FDG PET imaging.
    Chander S; Ergün EL; Westphal S; Powell W; Zerin JM; Nandkumar U
    Clin Nucl Med; 2004 Aug; 29(8):502-3. PubMed ID: 15249830
    [No Abstract]   [Full Text] [Related]  

  • 38. [Positron emission tomography for diagnosis of breast cancers].
    Yutani K; Nishimura T
    Nihon Rinsho; 2000 Apr; 58 Suppl():76-9. PubMed ID: 11025977
    [No Abstract]   [Full Text] [Related]  

  • 39. Is there a role for FDG PET in the diagnosis of musculoskeletal neoplasms?
    Messa C; Landoni C; Pozzato C; Fazio F
    J Nucl Med; 2000 Oct; 41(10):1702-3. PubMed ID: 11038001
    [No Abstract]   [Full Text] [Related]  

  • 40. Coincidence images lag PET in head-to-head comparisons.
    Hayes JC
    Diagn Imaging (San Franc); 1999 Jan; Suppl():IR39-40. PubMed ID: 11692373
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.